As a member of the antiapoptotic Bcl-2 family, BCL2L1 is hypomethylated and highly expressed in chemotherapy drug (e.g. cisplatin and paclitaxel) -resistant tumor cells in vitro and has been proven to be associated with drug resistance and recurrence of solid tumor cancer [20–23]. Here, BCL2 is linked to neoplasm.